furthermore , a subset of patients in group ivb ( 24/27 ) who could be considered as high-risk acute lymphoblastic leukemia on the basis of age , initial leukocyte count , hemoglobin , mediastinal mass or t- or b-cell markers showed an improved survival ( 73 % versus 43 % ) when compared to patients treated with conventional leukemia regimens .
C0023449
acute lymphoblastic leukemia
C0023418
regimens